Novo Nordisk A/S - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US6701002056

SecurityNVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionColdstream Capital Management Inc
Latest Disclosed Ownership43,342 shares
Latest Disclosed Value $ 1,592,808
Coldstream Capital Management Inc reports 1.51% increase in ownership of NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 8, 2026 - Coldstream Capital Management Inc filed a 13F-HR form disclosing ownership of 43,342 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (US:NVO) valued at $1,592,818 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 42,697 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of 1.51% during the quarter. The current value of the position is $1,820,364 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F NOVO-NORDISK A S ADR 670100205 43,342 645 1.51 1,593 -26.70 0.0171
2026-02-09 2025-12-31 13F NOVO-NORDISK A S ADR 670100205 42,697 -2,476 -5.48 2,172 -13.33 0.0280
2025-11-19 2025-09-30 13F NOVO-NORDISK A S ADR 670100205 45,173 -13,372 -22.84 2,507 -37.97 0.0338
2025-08-12 2025-06-30 13F NOVO-NORDISK A S ADR 670100205 58,545 6,828 13.20 4,041 12.50 0.0661
2025-05-13 2025-03-31 13F NOVO-NORDISK A S ADR 670100205 51,717 31,000 149.64 3,591 101.52 0.0765
2025-02-14 2024-12-31 13F NOVO-NORDISK A S ADR 670100205 20,717 -1,647 -7.36 1,782 -33.03 0.0380
2024-11-18 2024-09-30 13F/A-1 NOVO-NORDISK A S ADR 670100205 22,364 1,831 8.92 2,661 -9.18 0.0575
2024-11-18 2024-09-30 13F NOVO-NORDISK A S ADR 670100205 22,364 2,661
2024-08-07 2024-06-30 13F NOVO-NORDISK A S ADR 670100205 20,533 -287 -1.38 2,931 9.61 0.0714
2024-05-14 2024-03-31 13F NOVO-NORDISK A S ADR 670100205 20,820 4,224 25.45 2,673 55.77 0.0679
2024-02-09 2023-12-31 13F NOVO-NORDISK A S ADR 670100205 16,596 6,914 71.41 1,717 95.00 0.0480
2023-11-02 2023-09-30 13F NOVO-NORDISK A S ADR 670100205 9,682 4,816 98.97 880 11.82 0.0288
2023-08-03 2023-06-30 13F NOVO-NORDISK A S ADR 670100205 4,866 -298 -5.77 787 -4.14 0.0249
2023-05-15 2023-03-31 13F NOVO-NORDISK A S ADR 670100205 5,164 299 6.15 822 24.77 0.0276
2023-01-10 2022-12-31 13F NOVO-NORDISK A S ADR 670100205 4,865 -588 -10.78 658 8.40 0.0241
2022-08-08 2022-06-30 13F/A-1 NOVO-NORDISK A S ADR 670100205 5,453 5,453 607 0.0236
2022-05-11 2022-03-31 13F NOVO-NORDISK A S ADR 670100205 0 -4,187 -100.00 0 -100.00
2022-02-11 2021-12-31 13F NOVO-NORDISK A S ADR 670100205 4,187 4,187 469 0.0147
2016-08-09 2016-06-30 13F NOVO-NORDISK A S ADR 670100205 0 -9,640 -100.00 0 -100.00
2016-05-16 2016-03-31 13F NOVO-NORDISK A S ADR 670100205 9,640 9,640 0.00 522 0.0951
2016-02-04 2015-12-31 13F NOVO-NORDISK A S ADR 670100205 0 0 0 0.0000
2015-05-11 2015-03-31 13F Novo Nordisk A COM 670100205 0 -9,733 -100.00 0 -100.00
2015-02-11 2014-12-31 13F Novo Nordisk A COM 670100205 9,733 38 0.39 412 -10.82 0.1146
2014-11-13 2014-09-30 13F Novo Nordisk A COM 670100205 9,695 -2,815 -22.50 462 -20.07 0.1312
2014-08-14 2014-06-30 13F Novo Nordisk A COM 670100205 12,510 5 0.04 578 1.23 0.1696
2014-05-07 2014-03-31 13F Novo Nordisk A COM 670100205 12,505 10,004 400.00 571 23.59 0.1849
2014-02-14 2013-12-31 13F Novo Nordisk A COM 670100205 2,501 560 28.85 462 40.85 0.1489
2013-11-07 2013-09-30 13F Novo Nordisk A COM 670100205 1,941 27 1.41 328 10.44 0.1080
2013-08-14 2013-06-30 13F Novo Nordisk A COM 670100205 1,914 1,914 297 0.1004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.